CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
CannaPharmaRx's gross profit for the twelve months ending Sep 30, 2026 was -$1.54M. For fiscal 2025 it was -$2.08M.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.08M | – |
| FY2024 | Dec 31, 2024 | -$2.93M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$277.78K | – |
| Q2 FY2026 | Jun 30, 2026 | -$138.45K | – |
| Q1 FY2026 | Mar 31, 2026 | -$409.45K | – |
| Q4 FY2025 | Dec 31, 2025 | -$716.99K | – |
| Q3 FY2025 | Sep 30, 2025 | -$373.71K | – |
| Q2 FY2025 | Jun 30, 2025 | -$621.21K | – |
| Q1 FY2025 | Mar 31, 2025 | -$502.61K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.69M | – |
| Q3 FY2024 | Sep 30, 2024 | -$356.16K | – |
| Q2 FY2024 | Jun 30, 2024 | -$171.36K | – |
| Q1 FY2024 | Mar 31, 2024 | -$437.41K | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
See a number that looks wrong?